Որոնման արդյունքները - Vivek Redkar

  • Ցուցադրվում են 1 - 6 արդյունքները 6
Հստակեցնել արդյունքները
  1. 1
    Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants

    Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants ‌ Krishna Mohan Vadrevu, Brunda Ganneru, Siddharth Reddy, Harsh Jogdand, Dugyala Raju, Gajanan Sapkal, Pragya D. Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Kumar, Raches Ella, Priya Abraham, Sai Prasad, Krishna M. Ella

    Հրապարակվել է 2022
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  2. 2
    Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

    Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®) ‌ Chandramani Singh, Savita Verma, Prabhakar Reddy, Michael Diamond, David T. Curiel, Chintan Patel, Manish Kumar Jain, Sagar Vivek Redkar, Amit Bhate, Vivek Gundappa, Rambabu Konatham, Leelabati Toppo, Aniket Chandrakant Joshi, Jitendra Singh Kushwaha, Ajit Pratap Singh, Shilpa Bawankule, Raches Ella, Sai Prasad, Brunda Ganneru, Siddharth Reddy Chiteti, Sreenivas Kataram, Krishna Mohan Vadrevu

    Հրապարակվել է 2023
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  3. 3
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial ‌ Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, Sai Prasad, Siddharth Reddy, Vamshi Sarangi, Brunda Ganneru, Gajanan Sapkal, Pragya D. Yadav, Priya Abraham, Samiran Panda, Nivedita Gupta, Prabhakar Reddy, Savita Verma, Sanjay Kumar, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Venkat Rao, Randeep Guleria, Krishna M. Ella, Balram Bhargava

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  4. 4
    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

    Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a doub... ‌ Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, Dipankar Das, Dugyala Raju, Usha Praturi, Gajanan Sapkal, Pragya D. Yadav, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Chandra Sekhar Gillurkar, Jitendra Singh Kushwaha, Satyajit Mohapatra, Amit Bhate, Sanjay Rai, Samiran Panda, Priya Abraham, Nivedita Gupta, Krishna M. Ella, Balram Bhargava, Krishna Mohan Vadrevu

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:
  5. 5
    Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial

    Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial ‌ Raches Ella, Siddarth Reddy, William C. Blackwelder, Varsha Potdar, Pragya D. Yadav, Vamshi Sarangi, Sanjay Kumar, Suman Kanungo, Sanjay Rai, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Satyajit Mohapatra, Anil Kumar Pandey, Pajanivel Ranganadin, Raghvendra Gumashta, Manish Multani, Shameem Mohammad, Parul Bhatt, Laxmi Kumari, Gajanan Sapkal, Nivedita Gupta, Priya Abraham, Samiran Panda, Sai Prasad, Balram Bhargava, Krishna M. Ella, Krishna Mohan Vadrevu

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը
    Pré-impressão
    Պահել ցուցակում
    Պահպանված է:
  6. 6
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial ‌ Raches Ella, Siddarth Reddy, William C. Blackwelder, Varsha Potdar, Pragya D. Yadav, Vamshi Sarangi, Sanjay Kumar, Suman Kanungo, Sanjay Rai, Prabhakar Reddy, Savita Verma, Chandramani Singh, Sagar Vivek Redkar, Satyajit Mohapatra, Anil Kumar Pandey, Pajanivel Ranganadin, Raghvendra Gumashta, Manish Multani, Shameem Mohammad, Parul Bhatt, Laxmi Kumari, Gajanan Sapkal, Nivedita Gupta, Priya Abraham, Samiran Panda, Sai Prasad, Balram Bhargava, Krishna M. Ella, Krishna Mohan Vadrevu, Pradeep Aggarwal, V. Aglawe, Abdullhameed May Ali, Nitin Anand, N. Awad, Varun Bafna, G. Balasubramaniyam, Archana Bandkar, P Basha, V. Bharge, Amit Bhate, Sameer Bhate, V. Bhavani, Ramesh Bhosale, DV Chalapathy, Cc Chaubal, Deepak Chaudhary, Arun B. Chavan, Parth Desai, Dinesh Dhodi, Siddhartha Dutta, Rakesh Garg, Kapil Garg, Melvin George, Pankaj Goyal, Randeep Guleria, Sneh Lata Gupta, Mansi Jain, Mansi Jain, Sonal Jindal, Manju Kalra, Shashi Kant, Pooja Khosla, Prasad S. Kulkarni, Pradeep Kumar, Y Kumar, A. S. Majumdar, Prerna Meshram, Vaibhav Mishra, Satyajit Mohanty, Julie McCulloh Nair, Shivam Pandey, Samir Kumar x Dr. Samir Kumar Panigrahi, Bapugouda Sahebagouda Patil, Vrunda More Patil, Prashant Rahate, Vino S. Raj, Sunita Ramanand, Kiran Rami, Balaji Ramraj, S. Rane, Venkatarao Epari, N. Mallikarjuna Rao, R. Raphael, Goutham Reddy, Vivek Redkar, Sagar Vivek Redkar, Ashutosh Sachdeva, Jayanta Saha, Jyotiranjan Sahoo, Prakash Sampath, A. Savith, Mihir Shah, S. Lokesh, Rajeev Sharma, Priyanka Sharma, Deepak Sharma, Akhil Kant Singh, Jasdeep Singh, Prateek Singh, S. Sivaprakasam

    Հրապարակվել է 2021
    Ստացեք ամբողջական տեքստը Ստացեք ամբողջական տեքստը
    Artigo
    Պահել ցուցակում
    Պահպանված է:

Որոնման գործիքներ: